Browsing by Author Mok, T.

Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
Apr-2008A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cellsMa, B.; Goh, B.C.; Tan, E.H.; Lam, K.C.; Soo, R. ; Leong, S.S.; Wang, L.Z. ; Mo, F.; Chan, A.T.C.; Zee, B.; Mok, T.
2008A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cellsMa, B.; Lam, K.C.; Mo, F.; Chan, A.T.C.; Zee, B.; Mok, T.; Goh, B.C. ; Soo, R.; Wang, L.Z.; Tan, E.H.; Leong, S.S.
15-Feb-2012Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lungDe Lima Lopes Jr., G.; Segel, J.E.; Tan, D.S.W.; Do, Y.K. ; Mok, T.; Finkelstein, E.A. 
7-Oct-2011INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancerWu, Y.-L.; Park, K.; Soo, R.A. ; Sun, Y.; Tyroller, K.; Wages, D.; Ely, G.; Yang, J.C.-H..; Mok, T.
Sep-2005Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases: A multicenter phase II study by the cancer therapeutic research groupHo, W.M.; Ma, B.; Mok, T.; Yeo, W.; Lai, P.; Lim, R.; Koh, J.; Wong, Y.Y.; King, A.; Leow, C.K. ; Chan, A.T.C.